ACTRN12605000003673进行中（未招募）3 期
Maintaining skeletal health in postmenopausal women with surgically resected Stage I-IIIa hormone-receptor positive breast cancer who are receiving anastrozole, through the use of alendronate as determined by the Osteoporosis Australia Bone Maintenance Algorithm
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- Female
入选标准
- •Postmenopausal women- Adequately diagnosed and treated Stage I-IIIa early breast cancer- Oestrogen receptor and/or progesterone receptor positive breast cancer- Anastrozole is clinically indicated to be the best adjuvant strategy
排除标准
- •Clinical or radiological evidence of distant spread- prior treatment with bisphosphonates within the past 12 months
研究者
相似试验
尚未招募
Unknown
Problems in Musculoskeletal system in Women After MenopauseCTRI/2023/06/054027Priyal Shah
已完成
3 期
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm AssessmentBreast CancerNCT00122356Barwon Health303
进行中（未招募）
不适用
Prevention of Postmenopausal Bone Loss in Osteopenic Women with Alendronate given on a 70 mg Once-every two week Regimen : a 2-year, Double-blind, Placebo-controlled Clinical Trialosteopenia and postmenopausal patientEUCTR2006-005862-38-BECL Mont Godinne150
已完成
不适用
A Randomised Control Trial to Compare the Effects of Hydroxyapatite Preparations, Calcium Citrate and Calcium Carbonate on Serum Calcium and Markers of Bone Turnover in Healthy Postmenopausal Women.Vascular diseaseMetabolic and Endocrine - Other metabolic disordersMusculoskeletal - OsteoporosisCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemOsteoporosisACTRN12611000232932The University of Auckland100
招募中
不适用
Health communication survey in elderly womeFactors influencing health status and contact with health serviscesKCT0001335Korea Centers for Disease Control and Prevention400